维普期刊资源整合服务平台（V6.5）

72篇 您的检索式：作者名="Extra JM"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Anthracyclines vs taxanes plus trastuzumab in HER2-positive metastatic breast cancer (MBC): A cross trial comparison of pivotal studies 显示文摘	Malty M Chan S Extra JM	2005	J Clin Oncol2005，23，6：	1
2	Triple-negative breast cancer:histoclinical and molecular features,therapeutic management and perspectives显示文摘	Provansal M Tarpin C Extra JM	2013	Bull Cancer2013，100，5：	1
3	Primary chemotherapy for operable breast cancer:incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery显示文摘	Extra JM Carton M	2001	J Clin Oncol2001，19，：	1
4	Primary chemotherapy for operable breast cancer: Incidence and prognostic significance of ipsilateral breast tumor recurrence after breast conserving surgery 显示文摘	Rouzier R Extra JM Carton M	2001	J Clin Oncol2001，19，18：	1
5	Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patient s with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes 显示文摘	Rouzier R Extra JM Klijanienko J	2002	J Clin Oncol2002，20，5：	1
6	phamacokinetics and safety profile on oxaliplatin显示文摘	Extra JM Marty M Brienza S	1998	Semin Oncol1998，25，5：	1
7	Efficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study显示文摘	Extra JM Antoine EC Vincent-Salomon A	2010	Oncologist2010，15，8：	1
8	Phase 1 study of oxaliplatin in patient with advanced cancer显示文摘	Espie M Calvo F	1990	Cancer Chemother Pharmacol1990，25，：	1
9	Pharmaeokineties and safety Profile of oxaliPlatin显示文摘	Extra JM Marty M Brienza S	1998	SeminOneol1998，25，：	1
10	Pharmacokinetics and safety profile on Oxaliplatin 显示文摘	Extra JM Marty M Brienza S	1998	Semin Oncol1998，25，5：	1
11	Efficacy of trastuzumab in routine clinical practice and after pro* gressJon for metastatic breast cancer patients: the observa- tional Hermine study显示文摘	Extra JM Antoine EC Vincent - Salomon A	2010	Oncologist2010，15，8：	1
12	Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?显示文摘	Degeorges A Roquancourt A Extra JM	1998	Breast Cancer Res Treat1998，47，1：	1
13	Pharmacokinetics and safety profile of oxaliplatin显示文摘	Extra JM Marty M Brienza S		0，，2：	1
14	PhaseⅠstudy of oxaliplatin in patients with advanced cancer显示文摘	Extra JM Espie M Calvo F		0，，04：	1
15	Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery 显示文摘	Rouzier R Extra JM Carton M	2001	J Clin Oncol2001，19，：	1
16	Phase Ⅰ study of oxaliplatin in patients with advanced cancer显示文摘	Extra JM Espie M Cairo F	1990	Cancer Chemnther Pharmacol1990，25，4：	1
17	Efficacy and Tolerance of Vinorelbine and Fluorouracile Combination as First Line Chemotherapy of Advanced Breast Cancer:Result of a Phase Ⅱ Study Using a Sequential Group Method 显示文摘	Extra JM Bellissant E	1996	J Clin Oncol1996，14，12：	1
18	Phase I study of oxaliplatin in patients with advanced cancer 显示文摘	Extra JM Espie M Calvo F	1990	Cancer Chemother Pharmacol1990，25，4：	1
19	Phase I study of oxaliplatin in patients with advanced cancer显示文摘	Extra JM Espie M Calvo F	1990	Cancer Chemother Pharmacol1990，25，4：	1
20	Phase Ⅰ study of oxaliplatin in patients with advanced cancer显示文摘	Extra JM Espie M Calvo F		0，，04：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示